Peroxisome proliferator-activated receptor gamma (PPARγ) protects against pulmonary arterial hypertension (PAH)

G. Hansmann, V. A. de Jesus Perez, J. Powers, S. Schellong, L. Wang, T. Urashima, M. Rabinovitch (CA, United States Of America)

Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Session: Pathogenesis and novel therapeutic targets in pulmonary hypertension
Session type: Oral Presentation
Number: 222
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Hansmann, V. A. de Jesus Perez, J. Powers, S. Schellong, L. Wang, T. Urashima, M. Rabinovitch (CA, United States Of America). Peroxisome proliferator-activated receptor gamma (PPARγ) protects against pulmonary arterial hypertension (PAH). Eur Respir J 2007; 30: Suppl. 51, 222

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of peroxisome proliferator-activated receptor γ in pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary circulation II
Year: 2009

Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD
Source: Eur Respir J 2007; 30: 245-252
Year: 2007



Peroxisome proliferator-activated receptors: a therapeutic target in COPD?
Source: Eur Respir J 2008; 31: 502-508
Year: 2008



Diminished peroxisome proliferator-activated receptor (PPAR) regulation as a potential mechanism for the persistent inflammation in chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 856s
Year: 2006

Diminished peroxisome proliferator-activated receptor (PPAR) regulation as a potential mechanism for the persistent inflammation in chronic obstructive pulmonary disease
Source: Eur Respir Rev 2006; 15: 211-212
Year: 2006



Relationship between peroxisome proliferator-activated receptor α and neutrophils in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 452s
Year: 2004

Role of peroxisome proliferator activated receptor γ in COPD
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009

Peroxisome proliferator-activated receptor-α reduces inflammation and vascular leakage in a murine model of acute lung injury
Source: Eur Respir J 2008; 32: 1344-1353
Year: 2008



The effects of exercise training on peroxisome proliferator-activated receptor (PPAR) expression in skeletal muscle in COPD
Source: Annual Congress 2009 - Emerging physiology behind pulmonary rehabilitation
Year: 2009

The interaction of glucocorticoid and peroxisome proliferator-activated receptor γ agonist in asthmatic mice
Source: Eur Respir J 2006; 28: Suppl. 50, 226s
Year: 2006

Role of exogenous ligands for the peroxisome proliferator-activated receptor-β/δ in the development of bleomycin-induced lung injury
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010

Peroxisome proliferator-activated receptor γ inhibits acrolein-induced airway mucus hypersecretion in rats
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


Activation of airway epithelial cell inhibited by peroxisome proliferator-activated receptor γ
Source: Eur Respir J 2006; 28: Suppl. 50, 229s
Year: 2006

The relationship of peroxisome proliferator activated receptor γ ligands and IL-6 in sepsis of rats
Source: Annual Congress 2009 - Acute lung injury and biomarkers
Year: 2009

Impacts of peroxisome proliferator-activated receptor gamma activation on cigarette smoke-induced exacerbated response to bacteria
Source: Eur Respir J 2015; 45: 191-200
Year: 2015



The effect of peroxisome proliferator-activated receptor-? ligands on in vitro and in vivo models of COPD
Source: Eur Respir J 2014; 43: 409-420
Year: 2013



Peroxisome proliferator-activated receptor gamma antagonist, GW9662, inhibits microparticles generation by calcium ionophore-stimulated monocytes/macrophages
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008


PPAR-γ agonists as therapy for diseases involving airway neutrophilia
Source: Eur Respir J 2004; 24: 18-23
Year: 2004



Reduced expression of peroxisome proliferator-activated receptors (PPARs) in skeletal muscle of patients with COPD
Source: Annual Congress 2006 - Respiratory muscles
Year: 2006


Peroxisome proliferator activated receptor gamma (PPARγ) agonist rosiglitizone inhibits upregulation of mucin gene expression in two airway epithelial cell lines
Source: Eur Respir J 2005; 26: Suppl. 49, 97s
Year: 2005